ATP Citrate Lyase Inhibitors

ATP citrate lyase (ACL) inhibitors are a class of compounds that hold great promise in the field of metabolism and potential treatment for conditions such as obesity and metabolic syndrome ACL is a key enzyme involved in the production of fatty acids and inhibiting its activity can lead to a decrease in lipid synthesis and potentially result in weight loss By targeting ACL these inhibitors have the potential to regulate lipid metabolism and improve metabolic disorders Our company offers a range of potent and selective ATP citrate lyase inhibitors that can be utilized for various research and therapeutic applications

Catalog Number	Chemical Name	CAS #	Price
BC-0771	Bempedoic acid	738606-46-7	Online Inquiry
EI-0414	BMS-303141	943962-47-8	Online Inquiry
EI-1961	SB-204490	154566-12-8	Online Inquiry

Application

ATP Citrate Lyase Inhibitors have a wide range of applications in both research and medicine In the field of research these inhibitors are commonly utilized to study the role and function of ATP citrate lyase an enzyme involved in cellular metabolism By inhibiting this enzyme scientists can gain insights into its impact on various biological processes providing valuable information for drug discovery and development

In medicine ATP Citrate Lyase Inhibitors hold promise as potential therapeutics for various diseases ATP citrate lyase plays a crucial role in lipid synthesis and its overactivity has been implicated in conditions such as cancer obesity and metabolic disorders By inhibiting this enzyme these inhibitors have the potential to halt or slow down the progression of these diseases offering new treatment options for patients

Furthermore ATP Citrate Lyase Inhibitors may also have implications in the field of nutrition By modulating lipid metabolism these inhibitors have the potential to impact body weight and lipid levels which can be beneficial for individuals struggling with obesity or related conditions This presents an exciting avenue for developing novel interventions to address the global health challenges of overweight and obesity

Please note that all services are for research use only. Not intended for any clinical use.

ATP Citrate Lyase Inhibitors